Related Experiment Video
Updated: Jul 17, 2025
Biotinylated Cell-penetrating Peptides to Study Intracellular Protein-protein Interactions
Published on: December 20, 2017
Structural analysis of peptide binding to integrins for cancer detection and treatment
Mauricio Urquiza1, Daniela Benavides-Rubio1, Silvia Jimenez-Camacho1
1Chemistry Department, Faculty of Sciences, Universidad Nacional de Colombia, Carrera 30# 45-03, Ciudad Universitaria, Bogotá, Colombia.
Abstract:
Integrins are cell receptors involved in several metabolic pathways often associated with cell proliferation. Some of these integrins are downregulated during human physical development, but when these integrins are overexpressed in adult humans, they can be associated with several diseases, such as cancer. Molecules that specifically bind to these integrins are useful for cancer detection, diagnosis, and treatment. This review focuses on the structures of integrin-peptidic ligand complexes to dissect how the binding occurs and the molecular basis of the specificity and affinity of these peptidic ligands. Understanding these interactions at the molecular level is fundamental to be able to design new peptides that are more specific and more sensitive to a particular integrin. The integrin complexes covered in this review are α5β1, αIIbβ3, αvβ3, αvβ6, and αvβ8, because the molecular structures of the complex have been experimentally determined and their presence on tumor cancer cells are associated with a poor prognosis, making them targets for cancer detection and treatment.
Insights
This review examines integrin-peptidic ligand complexes, crucial for cancer detection and treatment. Understanding molecular interactions aids in designing targeted cancer therapies and diagnostic tools.
Area of Science:
- Molecular biology
- Biochemistry
- Oncology
Background:
- Integrins are cell receptors implicated in metabolic pathways and cell proliferation.
- Overexpression of certain integrins in adults is linked to diseases like cancer.
- Integrin-targeting molecules are valuable for cancer diagnostics and therapeutics.
Purpose of the Study:
- To review the molecular structures of integrin-peptidic ligand complexes.
- To elucidate the binding mechanisms, specificity, and affinity of peptidic ligands.
- To provide a foundation for designing novel, targeted cancer detection and treatment peptides.
Main Methods:
- Structural analysis of experimentally determined integrin-peptidic ligand complexes.
- Focus on integrin targets: α5β1, αIIbβ3, αvβ3, αvβ6, and αvβ8.
- Review of literature on molecular interactions and their relevance to cancer.
Main Results:
- Detailed insights into the molecular basis of integrin-peptidic ligand interactions.
- Identification of key structural features governing binding specificity and affinity.
- Established link between specific integrin expression and poor cancer prognosis.
Conclusions:
- Understanding integrin-ligand interactions is fundamental for developing targeted cancer therapies.
- Specific integrins (α5β1, αIIbβ3, αvβ3, αvβ6, αvβ8) are promising targets for cancer detection and treatment.
- Molecular-level insights facilitate the design of more effective and sensitive peptide-based drugs.
Related Concept Videos
01:15Activation of Integrins
In "outside-in signaling," external factors in the extracellular space bind to exposed ligand binding sites on integrins. This causes the inactive protein to undergo a conformational change to become active. Integrins are often clustered on the cell membrane. Repetitive and regularly spaced ligand binding...
01:10Integrins
Some ECM proteins assemble into a basement membrane to which the remaining components adhere. Proteoglycans typically form the bulk of the ECM while fibrous proteins, like collagen,...
01:17Intracellular Signaling Affects Focal Adhesions
Some...
01:25Selectins
02:04Protein-protein Interfaces
02:57Targeted Cancer Therapies
There are several types of targeted therapies against...